Cargando…

Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells

Peripheral tolerance to autoantigens is induced via suppression of self-reactive lymphocytes, stimulation of tolerogenic dendritic cells (DCs) and regulatory T (Treg) cells. Interleukin (IL)-27 induces tolerogenic DCs and Treg cells; however, it is not known whether IL-27 is important for tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomé, Rodolfo, Moore, Jason N., Mari, Elisabeth R., Rasouli, Javad, Hwang, Daniel, Yoshimura, Satoshi, Ciric, Bogoljub, Zhang, Guang-Xian, Rostami, Abdolmohamad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663690/
https://www.ncbi.nlm.nih.gov/pubmed/29163476
http://dx.doi.org/10.3389/fimmu.2017.01392
Descripción
Sumario:Peripheral tolerance to autoantigens is induced via suppression of self-reactive lymphocytes, stimulation of tolerogenic dendritic cells (DCs) and regulatory T (Treg) cells. Interleukin (IL)-27 induces tolerogenic DCs and Treg cells; however, it is not known whether IL-27 is important for tolerance induction. We immunized wild-type (WT) and IL-27 receptor (WSX-1) knockout mice with MOG(35–55) for induction of experimental autoimmune encephalomyelitis and intravenously (i.v.) injected them with MOG(35–55) after onset of disease to induce i.v. tolerance. i.v. administration of MOG(35–55) reduced disease severity in WT mice, but was ineffective in Wsx(−/−) mice. IL-27 signaling in DCs was important for tolerance induction, whereas its signaling in T cells was not. Further mechanistic studies showed that IL-27-dependent tolerance relied on cooperation of distinct subsets of spleen DCs with the ability to induce T cell-derived IL-10 and IFN-γ. Overall, our data show that IL-27 is a key cytokine in antigen-induced peripheral tolerance and may provide basis for improvement of antigen-specific tolerance approaches in multiple sclerosis and other autoimmune diseases.